OneSource’s global network of manufacturing and development facilities is designed to support complex pharmaceutical products across the full product lifecycle.
From biologics process development and sterile injectable manufacturing to softgel production and dedicated beta-lactam operations, each facility is purpose-built to support specific modalities, technologies, and stages of development. Together, they form an integrated infrastructure platform aligned to deliver scalable manufacturing, operational flexibility, and global regulatory compliance.
Complex pharmaceutical products require more than manufacturing capacity alone. They require infrastructure capable of supporting specialized processes, coordinated technology transfer, and consistent execution across development and commercial supply.
At OneSource, our facilities are designed to work together as a connected network, enabling:
Alignment between development and manufacturing
Flexible scale-up pathways across modalities
Reduced operational complexity and transfer risk
Integrated quality and regulatory oversight
This model allows programs to move efficiently from development through global commercialization.
| Facility Focus | Core Functions |
|---|---|
| Development Facilities | Process development, analytical characterization, scale-up studies |
| Manufacturing Facilities | Drug substance and drug product manufacturing, fill-finish, packaging |
| Specialized Production Sites | Softgel manufacturing, beta-lactam containment, sterile injectables |
| Integrated Delivery Systems | Device assembly, prefilled systems, patient-ready packaging |
A multi-modality manufacturing site supporting biologics, complex injectables, and drug-device-combination products through integrated drug substance and drug product operations.
Key capabilities include:
A research & development center supporting process optimization, analytical development, and scale-up readiness.
Key capabilities include:
A specialized sterile manufacturing facility supporting liquid, lyophilized, and device-integrated injectable products.
Key capabilities include:
A dedicated beta-lactam manufacturing facility designed for safe, segregated production of sterile penicillin products.
Key capabilities include:
A dedicated high-volume manufacturing facility supporting complex oral dosage forms and advanced softgel technologies.
Key capabilities include:
All OneSource facilities operate under integrated quality systems aligned with global regulatory expectations.
Across the network, facilities are approved by leading regulatory agencies including:
This regulatory foundation supports reliable supply into highly regulated global markets while maintaining consistent quality and operational control.
OneSource’s facilities are designed to support both emerging and commercial-stage programs, enabling clients to scale efficiently while maintaining continuity across development and manufacturing.
By combining specialized infrastructure with integrated operational oversight, OneSource delivers the flexibility, control, and manufacturing depth required for today’s increasingly complex pharmaceutical products.
Stay informed with the latest insights, industry perspectives, and technical resources from OneSource. Explore content designed to support informed decision-making across development, manufacturing, quality, and commercialization.